Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Zepbound (tirzepatide injection) hit the market as an injectable-only treatment, but patients often wonder whether a pill version exists. The good news: oral semaglutide tablets deliver similar weight loss benefits without needles, and compounded versions are available through licensed 503A pharmacies at transparent, flat monthly pricing.

Zepbound Delivery Format: Injectable Only

Zepbound contains tirzepatide, a dual GLP-1 and GIP receptor agonist engineered specifically for subcutaneous injection. The once-weekly pen delivery system requires a needle, which some patients embrace for convenience while others seek alternatives. Clinical trials demonstrated tirzepatide injection reduced body weight by up to 22% over 68 weeks in adults with obesity, making it one of the most potent GLP-1 class medications available.

Injectable delivery ensures consistent absorption through the subcutaneous tissue layer, allowing the medication to enter the bloodstream gradually and maintain steady hormone activity throughout the week. This pharmacokinetic profile underpins the medication's efficacy and is why the brand formulation was designed as an injection rather than a tablet from inception.

Oral Semaglutide as a Needle-Free Alternative

Oral semaglutide tablets represent a distinct GLP-1 medication that delivers weight loss benefits through tablet form, eliminating the injection requirement entirely. While semaglutide works through a single GLP-1 receptor pathway (versus tirzepatide's dual mechanism), randomized controlled trials show oral semaglutide produces meaningful weight reductions, with some patients achieving 10–15% body weight loss over 68 weeks. The oral formulation requires specific dosing instructions to maximize absorption, including taking the tablet on an empty stomach.

PlexusDx offers compounded oral semaglutide starting at $249 per month, providing access to this needle-free GLP-1 option without insurance or membership requirements. Your dose may need to go up during your treatment journey, but your price won't—pricing remains flat across the full commitment tier you select.

Comparing Injection vs. Oral Formats for Weight Loss

Both injectable and oral medications activate GLP-1 pathways to reduce appetite, slow gastric emptying, and improve blood sugar control—the core mechanisms behind weight loss. Injectable formulations (tirzepatide, semaglutide injection) typically achieve faster and more consistent peak drug levels because they bypass first-pass liver metabolism, whereas oral tablets must dissolve in the stomach and be absorbed through intestinal tissue. This bioavailability difference explains why injectable versions often produce slightly faster initial results, though oral formulations still deliver substantial weight reduction over time.

Patient adherence and lifestyle factors often matter more than the route itself. Some individuals prefer weekly injections as a simple, set-it-and-forget-it routine, while others prioritize avoiding needles entirely and opt for daily or weekly tablets. PlexusDx offers both compounded semaglutide injection and oral semaglutide, allowing your provider to match the delivery method to your preferences and medical situation.

PlexusDx Compounding Pharmacy Advantage

PlexusDx partners exclusively with licensed 503A compounding pharmacies—institutions that formulate medications under strict state and federal oversight to ensure sterility, potency, and purity. Unlike mass-manufactured brand medications, compounded formulations are prepared on-demand by pharmacists trained in GLP-1 therapy, allowing dose customization and flexible scheduling without the constraints of pre-filled pens. All medications serve all 50 states, require no insurance, and are HSA/FSA eligible, removing financial barriers to access.

When you select oral semaglutide or any GLP-1 medication through PlexusDx, you receive your prescription filled by a licensed compounding pharmacy and shipped directly to your home. Genetic testing through the PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) can identify your unique peptide-pathway predispositions—analyzing variants in GLP1R, GIPR, FTO, and MC4R—to help your provider optimize your medication choice and dose strategy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Oral starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is there a pill version of Zepbound?

No, Zepbound (tirzepatide) is exclusively an injection. However, oral semaglutide tablets offer a comparable GLP-1 pill alternative that delivers weight loss without needles. PlexusDx provides compounded oral semaglutide starting at $249 per month for patients who prefer tablet-based therapy.

Does oral semaglutide work as well as injected tirzepatide?

Both medications activate GLP-1 pathways and produce meaningful weight loss, but tirzepatide's dual GLP-1/GIP mechanism often generates slightly faster results. Oral semaglutide still achieves 10–15% body weight reduction in many patients and avoids needle requirements. Your provider can assess which option aligns best with your health goals and preferences.

How much does oral semaglutide cost at PlexusDx?

PlexusDx oral semaglutide starts at $249 per month with flat pricing across commitment tiers. No insurance, membership fees, or per-dose charges apply. HSA and FSA accounts are eligible, making this option accessible and financially transparent.

Are compounded GLP-1 medications safe and regulated?

Yes, PlexusDx exclusively partners with licensed 503A compounding pharmacies, which operate under strict state and federal pharmaceutical oversight. These facilities maintain sterility and potency standards equivalent to those required for brand medications, with routine inspections and quality audits to ensure safety.

How can genetic testing help me choose between oral and injectable GLP-1s?

The PlexusDx Precision Peptide Genetic Test analyzes 14 peptide pathways and 150+ genetic insights, including variants in GLP1R and GIPR genes that influence how your body responds to GLP-1 therapy. This personalized data helps your provider predict which medication format and dose strategy may work best for your unique biology, optimizing your weight loss outcomes.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves